Bladder Cancer Trial, Recruiting NCT07589413 Sponsor: Zhiping Wang Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07589413
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have suspected or confirmed bladder cancer of a specific type called urothelial carcinoma
  • People who are already scheduled to have a surgical procedure called TURBT (a procedure to remove bladder tumours)
  • People for whom enough blood samples can be collected to carry out DNA testing
  • People for whom complete medical and surgery-related records are available
  • People who are able to give informed consent and attend follow-up appointments as required by the study

Who may not be able to join:

  • People whose bladder cancer has been confirmed by pathology to be a type other than urothelial carcinoma
  • People who have had another cancer in the past 5 years, except for certain treated skin cancers or early-stage cervical cell changes
  • People who have previously had their bladder surgically removed, or who have already received cancer-fighting systemic treatment before enrolling
  • People whose blood samples are not of sufficient quality or do not yield enough DNA for the required testing
  • People who are pregnant or breastfeeding
  • People living with serious or uncontrolled health conditions that could interfere with study participation, such as active infection, certain heart conditions, severe psychiatric illness, or other conditions the trial team considers would make participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhiping Wang
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Plasma cfDNA Level From Before TURBT to Within 24 Hours After TURBT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov